RGEN logo
RGEN
Repligen

Biomanufacturing Expansion Will Create New Global Opportunities

AN
AnalystConsensusTarget
AnalystConsensusTarget
Not Invested
Consensus Narrative from 18 Analysts
Published
26 May 25
Updated
24 Jul 25
AnalystConsensusTarget's Fair Value
US$179.75
36.8% undervalued intrinsic discount
24 Jul
US$113.52
Loading
1Y
-31.9%
7D
-3.0%

Author's Valuation

US$179.7

36.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value